Chengdu Easton Biopharmaceuticals Co Ltd Defensive Interval Ratio
Chengdu Easton Biopharmaceuticals Co Ltd defensive interval ratio. Chengdu Easton Biopharmaceuticals Co Ltd (688513) has a Defensive Interval Ratio of 829 days as of June 2026. Defensive assets of CN¥1.51 Billion (cash CN¥-, short-term investments CN¥1.34 Billion, receivables CN¥167.37 Million) cover 829 days of daily cash needs of CN¥1.82 Million/day. See 688513 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of Chengdu Easton Biopharmaceuticals Co Ltd (2013–2025)
Defensive interval ratio of Chengdu Easton Biopharmaceuticals Co Ltd from 2013 to 2025. This chart shows how Chengdu Easton Biopharmaceuticals Co Ltd's Defensive Interval Ratio has evolved across 13 annual periods from 2013 to 2025. As of June 2026, the ratio stands at 829 days, meaning defensive assets of CN¥1.51 Billion can fund 829 days of operations without new revenue. Read debt load of Chengdu Easton Biopharmaceuticals Co Ltd for a breakdown of total debt and financial obligations.
Chengdu Easton Biopharmaceuticals Co Ltd Defensive Interval Ratio by Year (2013–2025)
Chengdu Easton Biopharmaceuticals Co Ltd defensive interval ratio by year from 2013 to 2025. The table below presents the year-by-year Defensive Interval Ratio for Chengdu Easton Biopharmaceuticals Co Ltd from 2013 to 2025, covering 13 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see 688513 asset base.
| Year | DIR (days) | Defensive Assets (CNY) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 554 days | CN¥939.29 Million | CN¥1.70 Million/day | CN¥- | CN¥758.00 Million | ▲ +100 days |
| 2024 | 454 days | CN¥741.23 Million | CN¥1.63 Million/day | CN¥- | CN¥452.35 Million | ▼ -54 days |
| 2023 | 508 days | CN¥920.15 Million | CN¥1.81 Million/day | CN¥- | CN¥741.78 Million | ▲ +26 days |
| 2022 | 482 days | CN¥698.53 Million | CN¥1.45 Million/day | CN¥- | CN¥516.36 Million | ▼ -9 days |
| 2021 | 490 days | CN¥580.74 Million | CN¥1.18 Million/day | CN¥- | CN¥453.84 Million | ▼ -193 days |
| 2020 | 683 days | CN¥721.12 Million | CN¥1.06 Million/day | CN¥- | CN¥570.00 Million | ▲ +486 days |
| 2019 | 197 days | CN¥149.50 Million | CN¥759.22K/day | CN¥- | CN¥- | ▼ 0 days |
| 2018 | 197 days | CN¥104.10 Million | CN¥528.14K/day | CN¥- | CN¥- | ▲ +46 days |
| 2017 | 151 days | CN¥53.85 Million | CN¥356.75K/day | CN¥- | CN¥- | ▼ -18 days |
| 2016 | 169 days | CN¥51.48 Million | CN¥304.86K/day | CN¥- | CN¥- | ▲ +139 days |
| 2015 | 30 days | CN¥3.54 Million | CN¥118.95K/day | CN¥- | CN¥- | ▲ +5 days |
| 2014 | 24 days | CN¥5.35 Million | CN¥218.76K/day | CN¥- | CN¥- | ▼ -13 days |
| 2013 | 37 days | CN¥8.77 Million | CN¥236.28K/day | CN¥- | CN¥3.00 Million | — |